共 96 条
[1]
Boyle P(1996)Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: meta-analysis of randomized clinical trials Urology 48 398-405
[2]
Gould AL(1997)Natural history of prostatism: risk factors for acute urinary retention J Urol 158 481-487
[3]
Roehrborn CG(1999)Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group Urology 53 473-480
[4]
Jacobsen SJ(1998)The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group N Engl J Med 338 557-563
[5]
Jacobsen DJ(2003)Identification of baseline clinical factors which predict medical treatment failure of benign prostatic hyperplasia: an observational cohort study Eur Urol 44 94-99
[6]
Girman CJ(1999)Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia Urology 53 581-589
[7]
Roberts RO(1999)Finasteride: an update of its use in the management of symptomatic benign prostatic hyperplasia Drugs 57 557-581
[8]
Rhodes T(1997)Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound Urology 49 548-557
[9]
Guess HA(2005)Influence of anthropometric measurements, age, and prostate volume on prostate-specific antigen levels in men with a low risk of prostate cancer Urology 66 819-823
[10]
Roehrborn CG(2003)Prostate-specific antigen as an estimator of prostate volume in the management of patients with symptomatic benign prostatic hyperplasia Eur Urol 44 695-700